Risk factors for mortality in patients with emphysematous pyelonephritis: a meta-analysis.
OBJECTIVE
Emphysematous pyelonephritis, an infection most commonly seen in cases of diabetes mellitus, is associated with considerable case fatality. We identified the factors associated with mortality in patients with emphysematous pyelonephritis and estimated the magnitude of the associations.


METHODS
PubMed was searched to identify studies reporting on risk factors of mortality in patients with emphysematous pyelonephritis. A meta-analysis of the eligible studies was performed.


RESULTS
Seven study cohorts, representing 175 patients with emphysematous pyelonephritis, were included in the meta-analysis. The overall mortality rate was 25%, ranging from 11% to 42%. Conservative treatment alone (OR 2.85, 95% CI 1.19-6.81), bilateral emphysematous pyelonephritis (OR 5.36, 95% CI 1.41-20.33), type I emphysematous pyelonephritis (OR 2.53, 95% CI 1.13-5.65) and thrombocytopenia (OR 22.68, 95% CI 4.4-116.32) were associated with increased mortality. Systolic blood pressure less than 90 mm Hg, serum creatinine greater than 2.5 mg/dl and disturbance of consciousness were also found to be associated with increased mortality. However, this finding was based on limited data. On the other hand, there was no association between mortality and diabetes mellitus (OR 0.32, 95% CI 0.05-1.99) in patients with emphysematous pyelonephritis.


CONCLUSIONS
The accumulated and analyzed evidence suggests that conservative treatment, type I emphysematous pyelonephritis, bilateral emphysematous pyelonephritis and thrombocytopenia seem to be significant risk factors for mortality in patients with emphysematous pyelonephritis. These data may be taken into consideration when treating patients with this devastating infection.
Falagas
Matthew E
ME
Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece. m.falagas@aibs.gr
Alexiou
Vangelis G
VG
Giannopoulou
Konstantina P
KP
Siempos
Ilias I
II
D002423:Cause of Death; D004646:Emphysema / Q000150:complications*; D006801:Humans; D011704:Pyelonephritis / Q000150:complications / Q000401:mortality*; D012307:Risk Factors